中文产业新闻评分66Chinese source
ImmunoPRISM二期：特立妥单抗对比Rd在高危冒烟型骨髓瘤2年PFS率92%对比49%
【2460】2年PFS率92% vs 49%，特立妥单抗改写高危冒烟型骨髓瘤治疗格局
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
【2460】2年PFS率92% vs 49%，特立妥单抗改写高危冒烟型骨髓瘤治疗格局
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.